Our studies were aimed at determining the functional properties of 18 known HNSCC-associated caspase-8 mutants (MTs) reported by TCGA (279 HNSCC tumors; [19]) and a prior cohort of 74 HNSCC tumors [20]. The gene discussed is CASP8; the disease is head and neck squamous cell carcinoma.